scorecardresearch
Add as a preferred source on Google
Monday, November 24, 2025
TopicVaccine authorisation

Topic: Vaccine authorisation

SII to manufacture India’s first qHPV vaccine against cervical cancer after DCGI approval

Cervical cancer in India is the 2nd most frequent cancer among women between 15-44 years of age. Currently, India is fully dependent on foreign manufacturers for the vaccine.

Why you won’t get Covishield, Covaxin at a chemist yet, despite full market approval

Covishield and Covaxin have been fully authorised only for use in adults, and can only be used in a ‘programmatic setting’, which means you’ll still have to register on CoWin.

Novavax’s Covid vaccine, made by Serum Institute of India, gets emergency use nod in Indonesia

Serum Institute of India, world's largest vaccine manufacturer, will market the nanoparticle protein-based vaccine in Indonesia under the brand name Covovax.

On Camera

Worker exploitation powers the firework industry in Tamil Nadu’s Sivakasi

For an industry globally classified as hazardous, protections such as health insurance and a provident fund for workers are necessities. In Sivakasi, they remain elusive.

172 countries & counting, India looks to hit new record in rice exports. But there’s a flip side

The industry forecasts exports are set to grow 16% in 2025-26, boosted by surplus domestic production and a drive to push into 26 underserved global markets with strong potential.

India and France to jointly manufacture HAMMER air-to-surface missile

Indigenisation level will progressively increase up to 60 percent with key sub-assemblies, electronics and mechanical parts being manufactured locally.

A tribute to Tejas. India’s delay culture is the real enemy in the skies

It is a brilliant, reasonably priced, and mostly homemade aircraft with a stellar safety record; only two crashes in 24 years since its first flight. But its crash is a moment of introspection.